|
UY35126A
(es)
|
2012-11-08 |
2014-05-30 |
Bristol Myers Squibb Co |
Ojo es alfa
|
|
MX2015005561A
(es)
|
2012-11-08 |
2015-07-23 |
Squibb Bristol Myers Co |
Compuestos de pirimidina sustituidos con alquil-amida utiles en la modulacion de interleucina 12 (il-12) interleucina 23 (il-23) y/o interferon alfa (ifn alfa).
|
|
PE20150953A1
(es)
*
|
2012-11-08 |
2015-06-20 |
Bristol Myers Squibb Co |
Compuestos de piridilo sustituidos con heteroarilo utiles como moduladores de cinasa
|
|
AR094537A1
(es)
|
2013-11-07 |
2015-08-12 |
Bristol Myers Squibb Co |
COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa
|
|
CN105992768B
(zh)
|
2013-12-10 |
2018-04-20 |
百时美施贵宝公司 |
用作IL‑12、IL‑23和/或IFNα响应的调节剂的咪唑并哒嗪化合物
|
|
UY35935A
(es)
|
2014-01-03 |
2015-06-30 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Compuestos de nicotinamida sustituida con heteroarilo como inhibidores de quinasa y moduladores de irak-4
|
|
WO2016001341A1
(en)
*
|
2014-07-03 |
2016-01-07 |
F. Hoffmann-La Roche Ag |
Sulfonylaminopyridine compounds, compositions and methods of use
|
|
WO2016022626A1
(en)
*
|
2014-08-06 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Heterocyclic cgrp receptor antagonists
|
|
EP3313840B1
(en)
|
2015-06-24 |
2019-07-24 |
Bristol-Myers Squibb Company |
Heteroaryl substituted aminopyridine compounds
|
|
KR102641263B1
(ko)
|
2015-06-24 |
2024-02-26 |
브리스톨-마이어스 스큅 컴퍼니 |
헤테로아릴 치환된 아미노피리딘 화합물
|
|
CN108026099B
(zh)
|
2015-06-24 |
2020-07-10 |
百时美施贵宝公司 |
经杂芳基取代的氨基吡啶化合物
|
|
KR102097878B1
(ko)
*
|
2015-11-26 |
2020-04-06 |
노파르티스 아게 |
디아미노 피리딘 유도체
|
|
TWI825663B
(zh)
|
2016-10-14 |
2023-12-11 |
美商林伯士拉克許米公司 |
Tyk2抑制劑及其用途
|
|
EP3528816A4
(en)
|
2016-10-21 |
2020-04-08 |
Nimbus Lakshmi, Inc. |
TYK2 INHIBITORS AND USES THEREOF
|
|
MA48602A
(fr)
*
|
2016-12-13 |
2020-03-18 |
Bristol Myers Squibb Co |
Composés hétéroaryle substitués par un amide alkyle d'oxyde de phosphine en tant que modulateurs des réponses il-12, il-23 et/ou ifn alpha
|
|
US10336752B2
(en)
|
2017-03-08 |
2019-07-02 |
Nimbus Lakshmi, Inc. |
TYK2 inhibitors, uses, and methods for production thereof
|
|
TW201900640A
(zh)
|
2017-05-11 |
2019-01-01 |
美商必治妥美雅史谷比公司 |
作為irak4抑制劑之噻吩并吡啶及苯并噻吩
|
|
TWI776810B
(zh)
*
|
2017-05-12 |
2022-09-11 |
瑞士商諾華公司 |
新穎二胺基吡啶衍生物
|
|
MY205416A
(en)
|
2017-07-28 |
2024-10-21 |
Takeda Pharmaceuticals Co |
Tyk2 inhibitors and uses thereof
|
|
JP7258903B2
(ja)
*
|
2017-11-21 |
2023-04-17 |
ブリストル－マイヤーズ スクイブ カンパニー |
スルホンピリジンアルキルアミド置換ヘテロアリール化合物
|
|
IL315310A
(en)
*
|
2017-12-26 |
2024-10-01 |
Kymera Therapeutics Inc |
Irak degraders and uses thereof
|
|
WO2019160875A1
(en)
|
2018-02-13 |
2019-08-22 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: soluble salts and aqueous formulations of pyronins
|
|
CN112118837B
(zh)
|
2018-02-13 |
2024-07-09 |
罗格斯新泽西州立大学 |
抗菌剂：o-烷基氘化派洛宁
|
|
WO2019173507A1
(en)
|
2018-03-06 |
2019-09-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents : arylalkylcarboxamido phloroglucinols
|
|
AR117398A1
(es)
|
2018-03-12 |
2021-08-04 |
Abbvie Inc |
Inhibidores de la señalización mediada por tirosina cinasa 2
|
|
CN111936486B
(zh)
*
|
2018-03-22 |
2023-09-22 |
百时美施贵宝公司 |
用作IL-12、IL-23和/或IFNα响应的调节剂的包含吡啶的杂环化合物
|
|
EP3817822A4
(en)
|
2018-07-06 |
2022-07-27 |
Kymera Therapeutics, Inc. |
PROTEIN DEGRADANTS AND USES THEREOF
|
|
CN113271940A
(zh)
|
2018-10-15 |
2021-08-17 |
林伯士拉克许米公司 |
Tyk2抑制剂和其用途
|
|
US12240840B2
(en)
*
|
2018-10-30 |
2025-03-04 |
Bristol-Myers Squibb Company |
Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha
|
|
CN113271938A
(zh)
|
2018-11-30 |
2021-08-17 |
林伯士拉克许米公司 |
Tyk2抑制剂和其用途
|
|
SG11202105424PA
(en)
|
2018-11-30 |
2021-06-29 |
Kymera Therapeutics Inc |
Irak degraders and uses thereof
|
|
WO2020154474A1
(en)
|
2019-01-23 |
2020-07-30 |
Nimbus Lakshmi, Inc. |
Tyk2 inhibitors and uses thereof
|
|
WO2020156311A1
(zh)
*
|
2019-01-28 |
2020-08-06 |
江苏豪森药业集团有限公司 |
一种哒嗪类衍生物抑制剂、其制备方法和应用
|
|
WO2021011724A1
(en)
|
2019-07-18 |
2021-01-21 |
Bristol-Myers Squibb Company |
Tricyclic heteroaryl compounds useful as irak4 inhibitors
|
|
KR20220035447A
(ko)
|
2019-07-18 |
2022-03-22 |
브리스톨-마이어스 스큅 컴퍼니 |
IRAK4 억제제로서 유용한 피라졸로[3,4-d]피롤로[1,2-b]피리다지닐 화합물
|
|
JP7573596B2
(ja)
|
2019-07-23 |
2024-10-25 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｉｒａｋ４阻害剤として有用なチエノピリジニルおよびチアゾロピリジニル化合物
|
|
EP4027995A4
(en)
|
2019-09-13 |
2023-08-23 |
Nimbus Saturn, Inc. |
HPK1 ANTAGONISTS AND THEIR APPLICATIONS
|
|
WO2021158495A1
(en)
|
2020-02-03 |
2021-08-12 |
Bristol-Myers Squibb Company |
Benzo[5,6][1,4]dioxino[2,3-b]pyridine compounds useful as irak4 inhibitors
|
|
JP7682191B2
(ja)
|
2020-02-03 |
2025-05-23 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｉｒａｋ４阻害剤として有用な三環ヘテロアリール化合物
|
|
CN112203515B
(zh)
*
|
2020-03-11 |
2022-08-02 |
西北农林科技大学 |
N-苄基苯甲酰胺类化合物作为除草剂的用途
|
|
EP4136073A1
(en)
*
|
2020-04-14 |
2023-02-22 |
Gossamer Bio Services, Inc. |
Substituted pyridines for the treatment of inflammatory diseases
|
|
KR20230004771A
(ko)
|
2020-04-28 |
2023-01-06 |
브리스톨-마이어스 스큅 컴퍼니 |
Il-12, il-23 및/또는 ifn알파 조정제로서의 치환된 n-(메틸-d3)피리다진-3-카르복스아미드 또는 n-(메틸-d3)-니코틴아미드 화합물
|
|
JP7537002B2
(ja)
*
|
2020-08-07 |
2024-08-20 |
南京薬石科技股▲フン▼有限公司 |
Ｃｄｋ９阻害剤およびその使用
|
|
CN114181257B
(zh)
*
|
2020-09-14 |
2025-02-14 |
四川科伦博泰生物医药股份有限公司 |
吡啶类化合物，包含其的药物组合物，其制备方法及其用途
|
|
EP4232425A4
(en)
|
2020-10-23 |
2024-07-24 |
Nimbus Clotho, Inc. |
Ctps1 inhibitors and uses thereof
|
|
US20240076285A1
(en)
*
|
2020-12-16 |
2024-03-07 |
Shankar Venkatraman |
Compounds and compositions for treating conditions associated with sting activity
|
|
AU2021413371A1
(en)
|
2020-12-30 |
2023-07-13 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
|
AU2022215844A1
(en)
|
2021-02-02 |
2023-09-14 |
Liminal Biosciences Limited |
Gpr84 antagonists and uses thereof
|
|
CN117098757A
(zh)
|
2021-02-02 |
2023-11-21 |
里米诺生物科学有限公司 |
Gpr84拮抗剂和其用途
|
|
CN117120090A
(zh)
|
2021-02-12 |
2023-11-24 |
林伯士萨顿公司 |
Hpk1拮抗剂和其用途
|
|
AU2022220043A1
(en)
|
2021-02-15 |
2023-08-31 |
Kymera Therapeutics, Inc. |
Irak4 degraders and uses thereof
|
|
AU2022222470A1
(en)
*
|
2021-02-19 |
2023-09-21 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
WO2022175752A1
(en)
|
2021-02-19 |
2022-08-25 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
US20240189309A1
(en)
*
|
2021-02-19 |
2024-06-13 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
AU2022223497A1
(en)
*
|
2021-02-19 |
2023-09-21 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
US11926625B2
(en)
|
2021-03-05 |
2024-03-12 |
Nimbus Saturn, Inc. |
HPK1 antagonists and uses thereof
|
|
EP4313989A4
(en)
|
2021-03-29 |
2025-03-05 |
Nimbus Saturn, Inc. |
HPK1 ANTAGONISTS AND USES THEREOF
|
|
EP4319756A4
(en)
|
2021-04-09 |
2025-02-26 |
Nimbus Clio, Inc. |
CBL-B MODULATORS AND USES THEREOF
|
|
CN119013277A
(zh)
|
2021-10-25 |
2024-11-22 |
凯麦拉医疗公司 |
Tyk2降解剂和其用途
|
|
CN118302168A
(zh)
|
2021-10-29 |
2024-07-05 |
凯麦拉医疗公司 |
Irak4降解剂和其制备
|
|
TW202339749A
(zh)
*
|
2021-12-16 |
2023-10-16 |
大陸商凌科藥業有限公司 |
Ｔｙｋ２抑制劑及其組合物和方法
|
|
WO2023108536A1
(en)
*
|
2021-12-16 |
2023-06-22 |
Lynk Pharmaceuticals Co. Ltd. |
Tyk2 inhibitors and compositions and methods thereof
|
|
EP4472967A2
(en)
|
2022-01-31 |
2024-12-11 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
|
CN116693449A
(zh)
|
2022-03-04 |
2023-09-05 |
上海致根医药科技有限公司 |
用作tyk2抑制剂的化合物、其制备方法及其在医药上的应用
|
|
CN119585250A
(zh)
*
|
2022-04-19 |
2025-03-07 |
蓝图药品公司 |
Kit抑制剂
|
|
EP4532485A1
(en)
*
|
2022-05-27 |
2025-04-09 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
WO2024028364A1
(en)
|
2022-08-02 |
2024-02-08 |
Liminal Biosciences Limited |
Aryl-triazolyl and related gpr84 antagonists and uses thereof
|
|
IL318576A
(en)
|
2022-08-02 |
2025-03-01 |
Liminal Biosciences Ltd |
Pyridoxine-substituted GPR84 antagonists and their uses
|
|
KR20250057800A
(ko)
|
2022-08-02 |
2025-04-29 |
리미널 바이오사이언시스 리미티드 |
헤테로아릴 카복스아마이드 및 관련 gpr84 길항제 및 이의 용도
|
|
WO2024249855A1
(en)
*
|
2023-06-02 |
2024-12-05 |
Idrx, Inc. |
Combination therapy comprising kit inhibitors for use in the treatment of cancer
|
|
TW202529769A
(zh)
|
2023-09-21 |
2025-08-01 |
日商武田藥品工業股份有限公司 |
Ｔｙｋ２抑制劑及其用途
|